StocksMedium•3 November 2026•
1 min read
Jazz Pharmaceuticals Stock Jumps 7.2% on Q2 Earnings Turnaround
Key Facts
1Jazz Pharmaceuticals shares rose 7.2% to $229.97 following the release of its second-quarter results.
2The company reported a net profit of $192.8 million in Q2, compared to a loss of $718.5 million in the same period last year.
3Quarterly revenue increased by 15.5% to $1,208.3 million.
Jazz Pharmaceuticals shares rose 7.2% to $229.97 following the release of its second-quarter results. Yahoo Finance reported that the company achieved a net profit of $192.8 million in Q2, a significant recovery from a loss of $718.5 million in the same period last year. Quarterly revenue increased by 15.5% to reach $1,208.3 million.
JAZZ closed at $214.44 on November 2, 2026, prior to this positive shift in financial performance. The stock price reaction follows a return to profitability and strong year-over-year revenue growth, signaling an operational recovery for the firm.